Saccomano Nicholas A
OnKure Therapeutics, Inc. · President and CEO
Saccomano Nicholas A is listed in filings as President and CEO at OnKure Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 24, 2026, including sale activity. Recent filings connect the profile to OnKure Therapeutics, Inc. (OKUR). The current snapshot covers public activity from Oct 8, 2024 to Jun 24, 2026. Reported amounts are shown as $378 to $50.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1.4k516 shares | SellApr 7, 2025 | $2.67 | $4.34 | |
| $1.2k358 shares | SellApr 4, 2025 | $3.33 | $4.34 | |
| $21088 shares | SellJun 23, 2025 | $2.38 | $4.34 | |
| $23188 shares | SellSep 22, 2025 | $2.62 | $4.34 | |
| $25887 shares | SellDec 22, 2025 | $2.97 | $4.34 | |
| $35786 shares | SellMar 23, 2026 | $4.16 | $4.34 |